Narva clinics has been acquired by Narva Åderbråckscenter AB

April 2020 — The founder and some key employees of Åderbråcksspecialisterna Narva Kirurg Center AB and Narva Derma Center AB (Narva) have completed an MBO.

Åderbråcksspecialisterna Narva Kirurg Center and Narva Derma Center are engaged in varicose vein treatments and aesthetic skincare. Founded in 2012, Narva is a leading Swedish pioneer in modern endovenous treatments for varicose veins. Most of its income comes from private paying patients but Narva is also one of only two market players contracted by the region of Stockholm to carry out varicose vein treatments. Based in Stockholm, Narva also operates several clinics around the country.

Narva Åderbråckscenter AB is a newly created company owned by Narva’s founder together with key employees. The new shareholders will develop Narva’s business plan in order to take advantage of the market opportunities within privately funded healthcare.

Vår roll i transaktionen

Oaklins’ team in Sweden acted as financial advisor in this transaction.

Uppdrag

Företagsförsäljning

Parter

“Together with Oaklins’ team in Sweden, we have carefully worked through the various strategic options at hand for a change of ownership in Narva. The team’s financial and strategic expertise, as well as their experience in the healthcare sector, have been crucial when evaluating the various alternatives.”

Stefan Nydahl

Founder, Narva Åderbråckscenter AB

Prata med transaktionsteamet

Adel Koubaa

Managing Partner

Stockholm, Sverige
Oaklins Sweden

Se profil Kontakta oss

Lars Gustafsson

Partner

Stockholm, Sverige
Oaklins Sweden

Se profil Kontakta oss

Relaterade transaktioner

UKAT Group has acquired Bayberry Limited

Riskkapital | Hälsovård

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Lär dig mer

Medicija has acquired Saulės Šeimos Medicinos Centras

Hälsovård

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Lär dig mer

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Hälsovård

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Lär dig mer